---
title: "Isradipine - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db00270-mesh-d006973-1.html
toc: false 
---


Path ID: `DB00270_MESH_D006973_1`
{% include image.html url="images/db00270-mesh-d006973-1.png" file="db00270-mesh-d006973-1.png" alt="db00270-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D017275">MESH:D017275 </a> | Isradipine | Drug |
| <a href="https://identifiers.org/InterPro:IPR005446">InterPro:IPR005446 </a> | Voltage-dependent calcium channel, L-type, alpha-1 subunit | GeneFamily |
| <a href="https://identifiers.org/InterPro:IPR000584">InterPro:IPR000584 </a> | Voltage-dependent L-type calcium channel subunit beta | GeneFamily |
| <a href="https://identifiers.org/InterPro:IPR013680">InterPro:IPR013680 </a> | Voltage-dependent calcium channel, alpha-2/delta subunit, conserved regio | GeneFamily |
| <a href="https://identifiers.org/UniProt:O95180">UniProt:O95180 </a> | Voltage-dependent T-type calcium channel subunit alpha-1H | Protein |
| <a href="https://identifiers.org/GO:0070509">GO:0070509 </a> | Calcium ion import | BiologicalProcess |
| <a href="https://identifiers.org/GO:0004687">GO:0004687 </a> | Myosin light chain kinase activity | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006939">GO:0006939 </a> | Smooth muscle contraction | BiologicalProcess |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | Vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D006973">MESH:D006973 </a> | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Isradipine | DECREASES ACTIVITY OF | Voltage-Dependent Calcium Channel, L-Type, Alpha-1 Subunit |
| Isradipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Beta |
| Isradipine | DECREASES ACTIVITY OF | Voltage-Dependent Calcium Channel, Alpha-2/Delta Subunit, Conserved Regio |
| Isradipine | DECREASES ACTIVITY OF | Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1H |
| Voltage-Dependent Calcium Channel, L-Type, Alpha-1 Subunit | POSITIVELY REGULATES | Calcium Ion Import |
| Voltage-Dependent L-Type Calcium Channel Subunit Beta | POSITIVELY REGULATES | Calcium Ion Import |
| Voltage-Dependent Calcium Channel, Alpha-2/Delta Subunit, Conserved Regio | POSITIVELY REGULATES | Calcium Ion Import |
| Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1H | POSITIVELY REGULATES | Calcium Ion Import |
| Calcium Ion Import | POSITIVELY REGULATES | Myosin Light Chain Kinase Activity |
| Myosin Light Chain Kinase Activity | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Smooth Muscle Contraction | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | AFFECTS RISK FOR | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00270#BE0000864](https://go.drugbank.com/drugs/DB00270#BE0000864)
